Industry

Hologic and Mary J. Blige Launch “Good Morning Gorgeous” Sweepstakes as a Wake-up Call to Increase Awareness of the Importance of Preventive Care

–Leader in Women’s Health and Presenting Sponsor of Mary J. Blige’s “Good Morning Gorgeous” Tour Offers Fans a Chance to Win Tickets to Concerts Taking Place Across the Nation this Fall– MARLBOROUGH, Mass.–(BUSINESS WIRE)–$HOLX #concerttour–Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, and Grammy award-winning and Accolade-nominated artist, producer, and entrepreneur Mary J. … [Read more…]

Mannatech Reports Second Quarter End 2022 Financial Results

FLOWER MOUND, Texas–(BUSINESS WIRE)–Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2022. Second Quarter End Results Second quarter net sales for 2022 were $35.0 million, a decrease of $7.5 million, or 17.7%, as compared to … [Read more…]

Insights on the Pediatric Imaging Global Market to 2027 – Surge in New Product Development and Launch of Advanced Imaging Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pediatric Imaging Market Research Report by Modality (Computed Tomography, Magnetic Resonance Imaging, and Ultrasound), Application, End-user, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Pediatric Imaging Market size was estimated at USD 9,705.90 … [Read more…]

Tardive Dyskinesia (TD) Treatment Drugs Market Report 2022: Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2029 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Tardive Dyskinesia (TD) Treatment Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029” report has been added to ResearchAndMarkets.com’s offering. Tardive dyskinesia (TD) is a rare neurological disorder due to long term use of antipsychotic medications which act on dopamine receptors. It … [Read more…]

Anti-Epileptic Drugs Market Report 2022: Increasing Awareness About Treatment With Anti-Epileptic Drugs, Patent Expiration and Approval of Pipeline Products to Drive Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Anti-epileptic Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029” report has been added to ResearchAndMarkets.com’s offering. This market analysis report on anti-epileptic drugs market provides a detailed analysis of the market. This report explains key market trends and aids industry leaders … [Read more…]

U.S. Healthcare Staffing Market to Reach $34.7 Billion by 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “U.S. Healthcare Staffing Market Size, Share & Trends Analysis Report by Type (Travel Nurse Staffing, Per Diem Nurse Staffing, Locum Tenens Staffing, Allied Healthcare Staffing), and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The U.S. healthcare staffing market size is expected to reach USD 34.7 billion by 2030, exhibiting a … [Read more…]

Fujifilm and Qure.ai Join Hands With IHVN to Accelerate TB Screening in Rural Nigerian Communities

– Fujifilm’s Xair ultra-portable handheld, battery powered X-ray machine will be deployed with Qure.ai’s AI-enabled Chest X-ray solution to screen presumptive TB cases – The partnership is aimed at augmenting active screening for TB in hotspots with the support of USAID and the Lagos State TB program. LAGOS, Nigeria–(BUSINESS WIRE)–#AI–The Institute of Human Virology in … [Read more…]

InnoCare Announces Acceptance of Supplemental New Drug Application for Orelabrutinib in Relapsed or Refractory Marginal Zone Lymphoma in China

BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced today that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) accepted a supplemental New Drug Application (sNDA) for Bruton’s tyrosine kinase (BTK) inhibitor orelabrutinib for the treatment of patients with relapsed … [Read more…]

Disclosure of data on Agaricus blazei mushroom, KA21’s immunity-enhancing mechanism, immunological enhancement effect confirmed by human clinical trials, and candida and other types of fungal infection, Toei Shinyaku

TOKYO–(BUSINESS WIRE)–On its website www.toeishinyaku.jp, Toei Shinyaku has disclosed data concerning the mechanism by which Agaricus blazei KA21 enhances immunity, its immunological enhancement effect as confirmed by human clinical trials, and candida and other types of fungal infection. Agaricus blazei KA21 product has been sold in the Japanese market as a supplement for the immune … [Read more…]

Disclosure of data on effects of Agaricus blazei mushroom, KA21 strain for improvement of hair loss & gray hair in human clinical trials and promotion of hair growth in mice, Toei Shinyaku

TOKYO–(BUSINESS WIRE)–On its website www.toeishinyaku.jp, Toei Shinyaku has disclosed data from human clinical trials concerning the effects of Agaricus blazei mushroom, KA21 strain for improvement of hair loss & gray hair, as well as its effects for promotion of hair growth in mice. Agaricus blazei mushroom, KA21 strain is being sold as a supplement within … [Read more…]